Helen R. Murphy
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Helen R. Murphy has a total of 13 co-authors. Here are the top co-authors by number of shared publications:
Balroop Johal
Department of Obstetrics, Ipswich Hospital NHS Trust
2 shared publicationsDuncan Fowler
Department of Diabetes and Endocrinology, Ipswich Hospital NHS Trust, Ipswich IP4 5PD
2 shared publicationsGerry Rayman
Department of Diabetes and Endocrinology, Ipswich Hospital NHS Trust, Ipswich IP4 5PD
2 shared publicationsKatherine Duffield
Elsie Bertram Diabetes Centre, Norfolk and Norwich University Hospital NHS Trust, Norwich
2 shared publicationsSusan Kelly
Departments of Diabetes and Obstetrics, Ipswich Hospital NHS Trust
2 shared publicationsC. Wadham
Department of Diabetes and Endocrinology, Ipswich Hospital, Ipswich and School of Psychology, University of Southampton, Southampton, UK
1 shared publication
Latest Publications
- Open Access
Effectiveness of continuous glucose monitoring in pregnant women with diabetes: randomised clinical trial
Objective To evaluate the effectiveness of continuous glucose monitoring during pregnancy on maternal glycaemic control, infant birth weight, and risk of macrosomia in women with type 1 and type 2 diabetes.Design Prospective, open label randomised controlled trial.Setting Two secondary care multidisciplinary obstetric clinics for diabetes in the United Kingdom.Participants 71 women with type 1 diabetes (n=46) or type 2 diabetes (n=25) allocated to antenatal care plus continuous glucose monitoring (n=38) or to standard antenatal care (n=33).Intervention Continuous glucose monitoring was used as an educational tool to inform shared decision making and future therapeutic changes at intervals of 4-6 weeks during pregnancy. All other aspects of antenatal care were equal between the groups.Main outcome measures The primary outcome was maternal glycaemic control during the second and third trimesters from measurements of HbA1c levels every four weeks. Secondary outcomes were birth weight and risk of macrosomia using birthweight standard deviation scores and customised birthweight centiles. Statistical analyses were done on an intention to treat basis.Results Women randomised to continuous glucose monitoring had lower mean HbA1c levels from 32 to 36 weeks’ gestation compared with women randomised to standard antenatal care: 5.8% (SD 0.6) v 6.4% (SD 0.7). Compared with infants of mothers in the control arm those of mothers in the intervention arm had decreased mean birthweight standard deviation scores (0.9 v 1.6; effect size 0.7 SD, 95% confidence interval 0.0 to 1.3), decreased median customised birthweight centiles (69% v 93%), and a reduced risk of macrosomia (odds ratio 0.36, 95% confidence interval 0.13 to 0.98).Conclusion Continuous glucose monitoring during pregnancy is associated with improved glycaemic control in the third trimester, lower birth weight, and reduced risk of macrosomia.Trial registration Current Controlled Trials ISRCTN84461581.
Open AccessEffectiveness of continuous glucose monitoring in pregnant women with diabetes: randomised clinical trial
Objective To evaluate the effectiveness of continuous glucose monitoring during pregnancy on maternal glycaemic control, infant birth weight, and risk of macrosomia in women with type 1 and type 2 diabetes.Design Prospective, open label randomised controlled trial.Setting Two secondary care multidisciplinary obstetric clinics for diabetes in the United Kingdom.Participants 71 women with type 1 diabetes (n=46) or type 2 diabetes (n=25) allocated to antenatal care plus continuous glucose monitoring (n=38) or to standard antenatal care (n=33).Intervention Continuous glucose monitoring was used as an educational tool to inform shared decision making and future therapeutic changes at intervals of 4-6 weeks during pregnancy. All other aspects of antenatal care were equal between the groups.Main outcome measures The primary outcome was maternal glycaemic control during the second and third trimesters from measurements of HbA1c levels every four weeks. Secondary outcomes were birth weight and risk of macrosomia using birthweight standard deviation scores and customised birthweight centiles. Statistical analyses were done on an intention to treat basis.Results Women randomised to continuous glucose monitoring had lower mean HbA1c levels from 32 to 36 weeks’ gestation compared with women randomised to standard antenatal care: 5.8% (SD 0.6) v 6.4% (SD 0.7). Compared with infants of mothers in the control arm those of mothers in the intervention arm had decreased mean birthweight standard deviation scores (0.9 v 1.6; effect size 0.7 SD, 95% confidence interval 0.0 to 1.3), decreased median customised birthweight centiles (69% v 93%), and a reduced risk of macrosomia (odds ratio 0.36, 95% confidence interval 0.13 to 0.98).Conclusion Continuous glucose monitoring during pregnancy is associated with improved glycaemic control in the third trimester, lower birth weight, and reduced risk of macrosomia.Trial registration Current Controlled Trials ISRCTN84461581.
- Open Access
- 1 November 2007
- Published by American Diabetes Association in Diabetes Care
- Vol. 30 (11) , 2785-2791
Changes in the Glycemic Profiles of Women With Type 1 and Type 2 Diabetes During Pregnancy
OBJECTIVE— To examine the changes in glycemic excursions that occur during pregnancy using continuous glucose monitoring and to compare patterns of glycemia in pregnant women with type 1 and type 2 diabetes.
- 1 November 2007
- Published by American Diabetes Association in Diabetes Care
- Vol. 30 (11) , 2785-2791
Open AccessChanges in the Glycemic Profiles of Women With Type 1 and Type 2 Diabetes During Pregnancy
OBJECTIVE— To examine the changes in glycemic excursions that occur during pregnancy using continuous glucose monitoring and to compare patterns of glycemia in pregnant women with type 1 and type 2 diabetes.
- 26 September 2007
- Published by Wiley in Diabetic Medicine
- Vol. 24 (11) , 1261-1268
Approaches to integrating paediatric diabetes care and structured education: experiences from the Families, Adolescents, and Children's Teamwork Study (FACTS)
Aims The Families, Adolescents and Children's Teamwork Study (FACTS) is a family‐centred structured education programme for children and adolescents with Type 1 diabetes. It aims to integrate group‐based diabetes education into routine care, enhance parental responsibility for self management and improve glycaemic control.Methods A randomized wait‐list control group study allocated participants to either the immediate (four educational sessions during year 1) or delayed intervention (four educational sessions during year 2). In both groups, glycated haemoglobin (HbA1c) was measured 3‐monthly and participants completed the Paediatric Quality of Life Inventory (PedsQL), Problem Areas in Diabetes Scale (PAID) and Diabetes Family Responsibility Questionnaire (DFRQ) before and after the intervention.Results Intention‐to‐treat analysis showed no significant difference in HbA1c or parental responsibility between participants randomized to the immediate or delayed programme. However, during 12 months’ follow‐up, families who attended ≥ 2 sessions reported increased parental involvement (P = 0.01), and in children/adolescents who attended ≥ 2 sessions HbA1c fell by 0.29% compared with an increase of 0.11% in non‐attenders (P = 0.04).Conclusion This family‐centred education programme has been integrated into paediatric diabetes care with potential benefits on parental involvement and glycaemic control, but further study is warranted before routine application into clinical care.
- 26 September 2007
- Published by Wiley in Diabetic Medicine
- Vol. 24 (11) , 1261-1268
Approaches to integrating paediatric diabetes care and structured education: experiences from the Families, Adolescents, and Children's Teamwork Study (FACTS)
Aims The Families, Adolescents and Children's Teamwork Study (FACTS) is a family‐centred structured education programme for children and adolescents with Type 1 diabetes. It aims to integrate group‐based diabetes education into routine care, enhance parental responsibility for self management and improve glycaemic control.Methods A randomized wait‐list control group study allocated participants to either the immediate (four educational sessions during year 1) or delayed intervention (four educational sessions during year 2). In both groups, glycated haemoglobin (HbA1c) was measured 3‐monthly and participants completed the Paediatric Quality of Life Inventory (PedsQL), Problem Areas in Diabetes Scale (PAID) and Diabetes Family Responsibility Questionnaire (DFRQ) before and after the intervention.Results Intention‐to‐treat analysis showed no significant difference in HbA1c or parental responsibility between participants randomized to the immediate or delayed programme. However, during 12 months’ follow‐up, families who attended ≥ 2 sessions reported increased parental involvement (P = 0.01), and in children/adolescents who attended ≥ 2 sessions HbA1c fell by 0.29% compared with an increase of 0.11% in non‐attenders (P = 0.04).Conclusion This family‐centred education programme has been integrated into paediatric diabetes care with potential benefits on parental involvement and glycaemic control, but further study is warranted before routine application into clinical care.